| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/30/2001 | WO2000040597A9 Method and composition for angiogenesis inhibition |
| 08/30/2001 | US20010018522 Neuropeptide y receptor ligand |
| 08/30/2001 | US20010018456 Use of a RAR-gamma-specific agonist ligand for increasing the rate of apoptosis |
| 08/30/2001 | US20010018451 Raloxifene, tamoxifen |
| 08/30/2001 | US20010018439 Antidiabetic agents |
| 08/30/2001 | US20010018430 Anticancer agents, psoriasis, restenosis, atherosclerosis |
| 08/30/2001 | US20010018427 Anticholesterol agent |
| 08/30/2001 | US20010018418 Method of promoting angiogenesis |
| 08/30/2001 | US20010018090 Administering 1-deoxynojiriniglin or mulberry tea &/or plant powders/extracts with carbohydrate source inhibits bonding of disaccharides which are passed on to large intesine for excretion |
| 08/30/2001 | US20010018068 Water insoluble substrate comprising creped nonwoven layer and cleansing component (lathering surfactant); cleaning/ conditioning skin/hair; disposable; materials handling |
| 08/30/2001 | DE10008274A1 Substituierte 8,8a-Dihydro-3aH-indeno[1,2-d]thiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted 8,8a-dihydro-3aH-indeno [1,2-d] thiazoles, process for their preparation and their use as medicaments |
| 08/30/2001 | CA2401356A1 Combination drug |
| 08/30/2001 | CA2401226A1 Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
| 08/30/2001 | CA2401113A1 Transporters and ion channels |
| 08/30/2001 | CA2401036A1 Pyridinylimidazoles |
| 08/30/2001 | CA2401013A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | CA2400923A1 Tyrosine kinase inhibitors |
| 08/30/2001 | CA2400892A1 Squalane containing ultra fine particles of burning residue of carbon and method for producing the same |
| 08/30/2001 | CA2400797A1 Therapeutic agents |
| 08/30/2001 | CA2400698A1 8,8a-dihydro-indeno[1,2-d]thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents |
| 08/30/2001 | CA2400694A1 Thiazolium compounds and treatments of disorders associated with protein aging |
| 08/30/2001 | CA2400692A1 Substituted 8, 8a-dihydro-3ah-indeno[1,2-d]thiazoles, a method for their production and their use as medicaments |
| 08/30/2001 | CA2400435A1 Novel compounds |
| 08/30/2001 | CA2400434A1 Novel compounds |
| 08/30/2001 | CA2400293A1 Novel compounds |
| 08/30/2001 | CA2400099A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 08/30/2001 | CA2400040A1 Integrin antagonists |
| 08/30/2001 | CA2399442A1 New drug combinations |
| 08/30/2001 | CA2399211A1 Foam-forming wound dressing |
| 08/30/2001 | CA2396960A1 Novel use of phenylheteroalkylamine derivatives |
| 08/29/2001 | EP1127882A1 Tetrazole compounds as thyroid receptor ligands |
| 08/29/2001 | EP1127578A1 Remedies for bone metabolic errors |
| 08/29/2001 | EP1127572A2 Use of flavones for treating cycloxygenase-2 mediated diseases |
| 08/29/2001 | EP1127151A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 08/29/2001 | EP1127117A1 Opg fusion protein compositions and methods |
| 08/29/2001 | EP1127074A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage |
| 08/29/2001 | EP1127071A1 Compounds with growth hormone releasing properties |
| 08/29/2001 | EP1127052A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 08/29/2001 | EP1126865A2 Methods and compositions for treating or preventing peripheral neuropathies |
| 08/29/2001 | EP1126858A1 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells |
| 08/29/2001 | EP1126854A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues |
| 08/29/2001 | EP1126852A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 08/29/2001 | EP1126849A1 Heterocyclic potassium channel inhibitors |
| 08/29/2001 | EP1126842A2 Inhibition of the formation of vascular hyperpermeability |
| 08/29/2001 | EP1126838A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 08/29/2001 | EP1126836A1 Benzamide potassium channel inhibitors |
| 08/29/2001 | EP1126832A2 Conductance of improperly folded proteins through the secretory pathway |
| 08/29/2001 | EP1054665B1 Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the treatment of hyperglycemia |
| 08/29/2001 | EP0828758B1 Chimeric fatty body-pro-grf analogs with increased biological potency |
| 08/29/2001 | EP0810868B1 Use of piperine as a gastrointestinal absorption enhancer |
| 08/29/2001 | EP0792290B1 Acylated insulin |
| 08/29/2001 | EP0751709B1 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 08/29/2001 | EP0666747B1 Use of 17alpha-dihydroequilenin for lowering cholesterol |
| 08/29/2001 | CN1310708A Substituted phenylamidines with antithrombotic action |
| 08/29/2001 | CN1310707A Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1H-benz[f] indoles, a method for the production thereof, and their use as medicaments |
| 08/29/2001 | CN1310620A Use of glucose uptake enhancer for reducing apoptosis |
| 08/29/2001 | CN1310613A Rapidly disintegrable solid preparation |
| 08/29/2001 | CN1310585A Process and production for promoting weight loss in overweight dogs |
| 08/29/2001 | CN1310180A New compound |
| 08/29/2001 | CN1310024A Microencapsulated compound nutrient complementing agent |
| 08/29/2001 | CN1309997A Hualu health article and its preparation |
| 08/29/2001 | CN1309996A Deer fetus oral liquid and its preparation |
| 08/29/2001 | CN1309985A Chinese medicine health tea capable of lowering blood pressure and blood lipoid |
| 08/29/2001 | CN1309984A Biological preparation for preventing and treating cardio-and cerebro-vascular disease and diabetes, nursing face and invigorating kidney and its preparation process |
| 08/29/2001 | CN1309979A Chinese medicine Tangzhi'an for treating peripheral nerve lesion of diabetes |
| 08/29/2001 | CN1309976A Diabetes treating medicine |
| 08/29/2001 | CN1309926A Preparation of additive for food, medicine and cosmetics and replenishing linolic acid and gamma-linolenic acid |
| 08/29/2001 | CN1070226C Gallnut oil and its extraction process and application in pharmacy |
| 08/29/2001 | CN1070077C Medicine for treating diabets and its preparing process |
| 08/29/2001 | CN1070069C Compound medicine for treating diabets |
| 08/28/2001 | US6281243 Derivatives of azetidine and pyrrolidine |
| 08/28/2001 | US6281215 4-(1-piperazinyl) benzoic acid derivatives, process for preparing them and their therapeutic applications |
| 08/28/2001 | US6281205 Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 08/28/2001 | US6281197 Inhibiting the export of a leaderless protein such as fgf from a cell by contacting the cell with a cardiac glycoside |
| 08/28/2001 | US6281175 Medical emulsion for lubrication and delivery of drugs |
| 08/28/2001 | US6280966 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus |
| 08/28/2001 | US6280959 Zinc chelated cell surface receptor ligands for use as agonist of dimeric cell surface receptors; for example, 2-bis(2,5-bis(2-benzimidazolylimino)-3A,6A-diphenyl-1,2,3,3a, 4,5,6,6a-octahydroimidazo(4,5-d)imidazole-N,N')-zinc(II) |
| 08/28/2001 | US6280776 Water and plant extracts |
| 08/28/2001 | CA2042113C Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors |
| 08/28/2001 | CA2041331C Nojirimycin derivatives |
| 08/23/2001 | WO2001061359A2 Identification of modulators of gpr41 or gpr42 activity |
| 08/23/2001 | WO2001061009A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061008A2 Polypeptides and nucleic acids encoding same |
| 08/23/2001 | WO2001061007A2 Fibroblast growth factor-23 molecules and uses thereof |
| 08/23/2001 | WO2001060992A2 Human protein tyrosine phosphatase, encoding dna and uses thereof |
| 08/23/2001 | WO2001060991A2 Human kinases |
| 08/23/2001 | WO2001060979A1 Pancreatic islet cell growth factors |
| 08/23/2001 | WO2001060835A1 Purine derivatives |
| 08/23/2001 | WO2001060832A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 08/23/2001 | WO2001060818A1 Lxr modulators |
| 08/23/2001 | WO2001060816A1 Kinase inhibitors |
| 08/23/2001 | WO2001060814A2 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/23/2001 | WO2001060813A1 Beta-alanine derivatives and their use as receptor antagonists |
| 08/23/2001 | WO2001060807A1 Aryloxyacetic acids for diabetes and lipid disorders |
| 08/23/2001 | WO2001060805A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
| 08/23/2001 | WO2001060804A1 Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 08/23/2001 | WO2001060786A1 Aminoalcohol derivatives |
| 08/23/2001 | WO2001060784A1 Aniline-derived ligands for the thyroid receptor |
| 08/23/2001 | WO2001060408A2 Microcompetiton and human disease |
| 08/23/2001 | WO2001060402A2 Proteosome influenza vaccine |